UPDATE: Piper Jaffray Upgrades Vertex Pharmaceuticals Ahead Of Expected Combination Approvals

By: via Benzinga
In a report published Monday, Piper Jaffray analyst Edward A. Tenthoff upgraded the rating on Vertex Pharmaceuticals Incorporated ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.